CARPL.ai, an innovative player in the radiology AI sector, has successfully secured USD 10 million in Series A funding, primarily led by the International Finance Corporation (IFC).
This funding round also saw participation from existing investor Stellaris Venture Partners and other contributors. The newly acquired capital will be instrumental in enhancing CARPL.ai's product offerings, fostering a robust global partner network, and driving commercial expansion in key regions such as North America, Europe, and emerging markets.
Established in 2021, CARPL.ai operates as a marketplace and enterprise platform that aggregates over 300 radiology AI applications from more than 100 partners. This approach allows healthcare organizations to efficiently build, test, deploy, and monitor AI solutions while maintaining a vendor-neutral stance.
The platform has gained traction among top healthcare institutions globally, including four of the five largest private radiology groups. Its influence extends to healthcare systems in diverse countries such as India, Brazil, and the UAE, showcasing its potential to significantly enhance AI adoption in the healthcare sector.
This funding marks a pivotal moment for CARPL.ai, as it positions itself to lead the charge in integrating AI into healthcare workflows, which could transform diagnostics and patient care on a global scale.